Do you mean “isoniazid patent” or a specific patent number?
“Isoniazid” is a long-established tuberculosis medicine, so “isoniazid patent” searches usually fall into one of these categories: when the original patents expired, whether any patents cover newer formulations, or what patents exist for combination products. With only the phrase provided, I can’t identify the exact patent or product you mean.
If you share either:
- the drug/formulation (e.g., tablet, injection, fixed-dose combination), or
- a country (US, EP, India, etc.), or
- the patent number/title,
I can narrow the answer to that specific filing.
Has isoniazid’s core patent protection already expired?
For first-generation medicines like isoniazid, the original compound patents are generally well past expiration because the drug has been in clinical use for decades. In that situation, the market typically shifts to generics and later, narrower patents (if any) can exist for improvements such as manufacturing processes, specific formulations, or delivery methods rather than for the original isoniazid molecule.
Could there still be patents related to isoniazid today?
Even when the original compound is no longer under patent, companies sometimes hold patents on:
- specific manufacturing processes,
- particular salt forms or stabilized formulations,
- controlled-release or alternate delivery approaches,
- fixed-dose combinations (for example, isoniazid combined with other TB drugs in a single pill).
Whether any such patents apply depends on the country and the exact product/label.
What do people usually look up when they search “isoniazid patent”?
Searches commonly target:
- “When did the isoniazid patent expire in [country]?”
- “Is there a patent on generic isoniazid?”
- “Are there patents on isoniazid + rifampin/pyrazinamide combinations?”
- “Are there patents on isoniazid injection vs tablets?”
Each question points to different patent documents and sometimes to different exclusivity rules (not just patents).
Which country’s patent system matters?
Patent and exclusivity timelines differ by jurisdiction, and the answer can change depending on where you look (for example, US vs EP vs India). If you tell me the country, I can tailor the timeline and what to check (patent expiry vs regulatory exclusivity).
What I need from you to give a precise answer
Reply with one of the following so I can give an accurate, specific response:
1) “Isoniazid patent expiry in [country]”
2) “Patents for isoniazid tablets/injection in [country]”
3) “Patent number: ______”
4) “Isoniazid + [other drug] fixed-dose combination in [country]”
Sources: none (no provided sources in the prompt).